These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 27911432
21. [. Oсumethyl in the treatment of allergic diseases of eyelids and conjunctiva]. Marchenko NR. Vestn Oftalmol; 2016; 132(5):81-85. PubMed ID: 27911431 [Abstract] [Full Text] [Related]
22. A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis. Rosenwasser LJ, Mahr T, Abelson MB, Gomes PJ, Kennedy K. Allergy Asthma Proc; 2008; 29(6):644-53. PubMed ID: 19063816 [Abstract] [Full Text] [Related]
23. Clinical efficacy of eyelid hygiene in blepharitis and meibomian gland dysfunction after cataract surgery: a randomized controlled pilot trial. Eom Y, Na KS, Hwang HS, Cho KJ, Chung TY, Jun RM, Ko BY, Chun YS, Kim HS, Song JS. Sci Rep; 2020 Jul 16; 10(1):11796. PubMed ID: 32678131 [Abstract] [Full Text] [Related]
24. Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD. Guillon M, Maissa C, Wong S. Eye Contact Lens; 2012 Sep 16; 38(5):306-12. PubMed ID: 22890228 [Abstract] [Full Text] [Related]
26. Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G. Ocul Surf; 2014 Apr 16; 12(2):146-54. PubMed ID: 24725326 [Abstract] [Full Text] [Related]
27. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Greiner JV, Udell IJ. Clin Ther; 2005 May 16; 27(5):568-77. PubMed ID: 15978305 [Abstract] [Full Text] [Related]
28. Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study. Doan S, Chiambaretta F, Baudouin C, ESPOIR study group. J Fr Ophtalmol; 2014 Dec 16; 37(10):763-72. PubMed ID: 25282620 [Abstract] [Full Text] [Related]
29. Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model. McLaurin E, Narvekar A, Gomes P, Adewale A, Torkildsen G. Cornea; 2015 Oct 16; 34(10):1245-51. PubMed ID: 26266427 [Abstract] [Full Text] [Related]
30. Effects of corneal nerve density on the response to treatment in dry eye disease. Kheirkhah A, Dohlman TH, Amparo F, Arnoldner MA, Jamali A, Hamrah P, Dana R. Ophthalmology; 2015 Apr 16; 122(4):662-8. PubMed ID: 25542519 [Abstract] [Full Text] [Related]
31. Efficacy of topical N-acetylcysteine in the treatment of meibomian gland dysfunction. Akyol-Salman I, Azizi S, Mumcu U, Baykal O. J Ocul Pharmacol Ther; 2010 Aug 16; 26(4):329-33. PubMed ID: 20653477 [Abstract] [Full Text] [Related]
32. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Prabhasawat P, Tesavibul N, Mahawong W. Cornea; 2012 Dec 16; 31(12):1386-93. PubMed ID: 23135530 [Abstract] [Full Text] [Related]
33. Assessment of tear osmolarity and other dry eye parameters in post-LASIK eyes. Hassan Z, Szalai E, Berta A, Modis L, Nemeth G. Cornea; 2013 Jul 16; 32(7):e142-5. PubMed ID: 23665645 [Abstract] [Full Text] [Related]
34. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis. Mortemousque B, Bourcier T, Khairallah M, Messaoud R, Brignole-Baudouin F, Renault D, Rebika H, Brémond-Gignac D, Ketotifen Study Group. J Fr Ophtalmol; 2014 Jan 16; 37(1):1-8. PubMed ID: 24388379 [Abstract] [Full Text] [Related]
35. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Greiner JV. Curr Eye Res; 2012 Apr 16; 37(4):272-8. PubMed ID: 22324772 [Abstract] [Full Text] [Related]
36. Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis. Khurana S, Sharma N, Agarwal T, Chawla B, Velpandian T, Tandon R, Titiyal JS. Eye Contact Lens; 2010 Jul 16; 36(4):210-4. PubMed ID: 20531202 [Abstract] [Full Text] [Related]
37. Blepharitis: current strategies for diagnosis and management. Jackson WB. Can J Ophthalmol; 2008 Apr 16; 43(2):170-9. PubMed ID: 18347619 [Abstract] [Full Text] [Related]
38. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS. Acta Ophthalmol; 2009 Aug 16; 87(5):549-54. PubMed ID: 18631332 [Abstract] [Full Text] [Related]
39. Comparative study of the efficacy of different treatment options in patients with chronic blepharitis. Arrúa M, Samudio M, Fariña N, Cibils D, Laspina F, Sanabria R, Carpinelli L, Mino de Kaspar H. Arch Soc Esp Oftalmol; 2015 Mar 16; 90(3):112-8. PubMed ID: 25542616 [Abstract] [Full Text] [Related]
40. In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Shimazaki J, Fujishima H, Tsubota K. Ophthalmology; 2012 Oct 16; 119(10):1961-8. PubMed ID: 22717457 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]